Effect of Benralizumab in Patients With Severe Eosinophilic Asthma and Chronic Rhinosinusitis With Nasal Polyps: A Case Series.

Chandala Chitguppi Prachi N PatelAlan GandlerKira MurphyTawfiq Khoury MdPamela MonostraStephanie BorkElina ToskalaMindy RabinowitzMarc RosenGurston NyquistJessica Most

Published in: American journal of rhinology & allergy (2020)

Usage of benralizumab in patients with SA and CRSwNP can lead to significantly improved asthma control, lung function, and sinonasal quality of life. Additionally, in this patient population, there was a subset of patients that showed a significant reduction in polyp burden.

Keyphrases

chronic rhinosinusitis
lung function
chronic obstructive pulmonary disease
cystic fibrosis
air pollution
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
allergic rhinitis
early onset
patient reported outcomes